.0om_8_rwqa5jm.png&w=1920&q=75)
Prime BioTech SME Limited (PRIMEBIO)
Bidding Dates
09 Jun
to 11 Jun 2026
Price Band
₹110 - ₹115
Per Equity Share
Minimum Investment
₹1,32,000
1200 Shares (1 Lot)
IPO Subscription Bidding Status
| Investor Category | Subscription Status |
|---|---|
| Retail Individual | 4.85x |
| Qualified Institutional Buyers (QIB) | 11.76x |
| Non-Institutional Investors (NII) | 1x |
| Total Bids Cumulative | 17.61x |
* Note: Subscription figures are updated in real-time on bidding days based on exchange feeds.
Listing Price Estimator
IPO GMP: ₹42 (36.5% premium)
Grey Market Premium Trend
Past 3 Days| Date | GMP | Est. Listing Price |
|---|---|---|
| Latest Active | ₹42 | ₹157 |
| 1 Day Prior | ₹37 | ₹152 |
| 2 Days Prior | ₹34 | ₹149 |
Tentative IPO Timetable
Lot Size & Investment Limits
SEBI Limits| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | 1200 Shares | ₹1,32,000 |
| Retail Maximum | 1 Lot | 1200 Shares | ₹1,32,000 |
| HNI / NII Minimum | 2 Lots | 2400 Shares | ₹2,64,000 |
Retail Limit: ₹2 Lakhs | NII Min Limit: ₹2 Lakhs | NII Big Limit: ₹10 Lakhs
Key Performance Indicators (KPIs)
Comparative Restated Financials
| Financial Indicator | 31-Mar-2023 | 31-Mar-2024 | 31-Mar-2025 |
|---|---|---|---|
| Total Assets | 35.84 | 47.04 | 58.24 |
| Total Revenue | 20.16 | 26.46 | 32.76 |
| Profit After Tax (PAT) | 1.57 | 2.26 | 3.06 |
| Net Worth | 19.04 | 24.99 | 30.94 |
| Reserves & Surplus | 13.44 | 17.64 | 21.84 |
| Total Borrowings | 13.86 | 11.97 | 10.08 |
About Prime BioTech SME Limited
Prime BioTech is an innovative manufacturer of plant-based active ingredients for cosmetics and health supplements.
Competitive Strengths
- Robust business model and scalable operation setup.
- Experienced board of directors and technical management team.
- Consistent track record of revenue performance in core segments.
Objects of the Issue
Funding working capital requirements for technology projects.
Investment in product research & development and IT infrastructure.
Funding inorganic growth through acquisitions.
General corporate purposes.
Broker & Analyst Recommendations
| Advisor / Brokerage | Verdict | Rating |
|---|---|---|
| Chittorgarh IPO Advisory | Subscribe | 4/5 |
| Dilip Davda (Analyst) | Subscribe | 3.5/5 |
| SMC Global | Subscribe | 3/5 |
| Choice Equity Brokers | Subscribe | 4/5 |
Disclaimer: Broker reviews, ratings, and consensus recommendations are aggregated from public analyst estimates and research reports for educational purposes. Grey Market Premium (GMP) indicators represent unofficial market sentiments, are highly speculative, and do not guarantee actual listing-day performance. Investing in securities is subject to market risks; please perform your own diligence or consult a SEBI registered investment advisor before bidding.
Company Contact Info
Prime BioTech SME Limited Ltd.
Registrar Contact Info
Link Intime India Private Ltd.
.0y~oc9pnpvecv.png&w=640&q=75)